EVALUATING VACCINATION EFFECTIVENESS OF GROUP-SPECIFIC FRACTIONAL-DOSE STRATEGIES

被引:0
|
作者
Chen, Zhimin [1 ,2 ]
Liu, Kaihui [3 ]
Liu, Xiuxiang [2 ]
机构
[1] Guangdong Polytech Normal Univ, Sch Math & Syst Sci, Guangzhou 510665, Peoples R China
[2] South China Normal Univ, Sch Math Sci, Guangzhou 510631, Peoples R China
[3] Jiangsu Univ, Fac Sci, Zhenjiang 212013, Jiangsu, Peoples R China
来源
关键词
multi-group epidemic model; fractional-dose vaccines; group-specific vaccination; the final size; INACTIVATED POLIOVIRUS VACCINE; YELLOW-FEVER VACCINE; FINAL SIZE; INFLUENZA; EPIDEMIC; IMMUNOGENICITY; SAFETY; MODEL;
D O I
10.3934/dcdsb.2021062
中图分类号
O29 [应用数学];
学科分类号
070104 ;
摘要
In this paper, we formulate a multi-group SIR epidemic model with the consideration of proportionate mixing patterns between groups and group-specific fractional-dose vaccination to evaluate the effects of fractionated dosing strategies on disease control and prevention in a heterogeneously mixing population. The basic reproduction number R-0, the final size of the epidemic, and the infection attack rate are used as three measures of population-level implications of fractionated dosing programs. Theoretically, we identify the basic reproduction number, R-0, establish the existence and uniqueness of the final size and the final size relation with R-0, and obtain explicit calculation expressions of the infection attack rate for each group and the whole population. Furthermore, the simulation results suggest that dose fractionation policies take positive effects in lowering the R-0, decreasing the final size and reducing the infection attack rate only when the fractional-dose influenza vaccine efficacy is high enough rather than just similar to standard-dose. We find evidences that fractional-dose vaccination in response to influenza vaccine shortages take negative community-level effects. Our results indicate that the role of fractional dose vaccines should not be overestimated even though fractional dosing strategies could extend the vaccine coverage.
引用
收藏
页码:717 / 748
页数:32
相关论文
共 34 条
  • [21] Evaluating the costs of cholera illness and cost-effectiveness of a single dose oral vaccination campaign in Lusaka, Zambia
    Tembo, Tannia
    Simuyandi, Michelo
    Chiyenu, Kanema
    Sharma, Anjali
    Chilyabanyama, Obvious N.
    Mbwili-Muleya, Clara
    Mazaba, Mazyanga Lucy
    Chilengi, Roma
    PLOS ONE, 2019, 14 (05):
  • [22] Using an AEFI Parent Diary Card Following Fractional-Dose Yellow Fever (fYF) Vaccination in Uganda; a Tool for Consideration for Future Clinical Trials in Low- and Middle-Income Countries
    Sciarratta, C.
    Sserunga, M. Najjengo
    Sekiziyivu, A. B.
    Lubega, I.
    Nakato, W. Nansozi
    Twinomuhwezi, E.
    Tumwine, C.
    Wasswa, C. Kaliisa
    Doshi, R.
    Chu, S.
    Gidudu, J.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 116 : S116 - S117
  • [23] Evaluating the Effectiveness of Probiotic and Multivalent Vaccination Strategies in Mitigating Bacterial Chondronecrosis with Osteomyelitis Lameness Using a Hybrid Challenge Model
    Anthney, Amanda
    Alharbi, Khawla
    Perera, Ruvindu
    Do, Anh Dang Trieu
    Asnayanti, Andi
    Onyema, Reginald
    Reichelt, Sara
    Meuter, Antoine
    Jesudhasan, Palmy R. R.
    Alrubaye, Adnan A. K.
    ANIMALS, 2025, 15 (04):
  • [24] Booster vaccination with a fractional dose of an oral cholera vaccine induces comparable vaccine-specific antibody avidity as a full dose: A randomised clinical trial
    Mottram, Lynda
    Lundgren, Anna
    Svennerholm, Ann-Mari
    Leach, Susannah
    VACCINE, 2020, 38 (03) : 655 - 662
  • [25] WHEN IS IT VALUABLE FOR COVID-19 BOOSTER DOSE?: A TRANSMISSION DYNAMICS MODEL-BASED EFFECTIVENESS AND COST-EFFECTIVENESS ANALYSIS OF TWO BOOSTER DOSE VACCINATION PRIORITY STRATEGIES IN MAINLAND CHINA
    Zhou, D.
    Shao, T.
    Shao, H.
    Tu, Y.
    Tang, Y.
    Zhou, J.
    Malone, D. C.
    Tang, W.
    VALUE IN HEALTH, 2022, 25 (07) : S466 - S466
  • [26] Response to Shami et al. 'Evaluating the cost-effectiveness of a sequential pneumococcal vaccination compared to single dose vaccination strategy for adults in Hong Kong' (Hum Vacc Immunother 2020)
    Buchwald, Ulrike K.
    Folaranmi, Temitope
    Weiss, Thomas
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (01) : 173 - 175
  • [27] A phase IIA extension study evaluating the effect of booster vaccination with a fractional dose of RTS,S/AS01E in a controlled human malaria infection challenge
    Moon, James E.
    Greenleaf, Melissa E.
    Regules, Jason A.
    Debois, Muriel
    Duncan, Elizabeth H.
    Sedegah, Martha
    Chuang, Ilin
    Lee, Cynthia K.
    Sikaffy, April K.
    Garver, Lindsey S.
    Ivinson, Karen
    Angov, Evelina
    Morelle, Danielle
    Lievens, Marc
    Ockenhouse, Christian F.
    Ngauy, Viseth
    Ofori-Anyinam, Opokua
    VACCINE, 2021, 39 (43) : 6398 - 6406
  • [28] EVALUATING THE EFFECTIVENESS OF OVARIAN TUMOUR RISK ASSESSMENT STRATEGIES IN A REAL-WORLD NATIONAL SETTING - IN COLLABORATION WITH THE DUTCH GYNAECOLOGICAL ONCOLOGY AUDIT COLLABORATOR GROUP AND THE PALGA GROUP
    Koch, Anna H.
    Lems, Esther
    Algera, Marc D.
    Van Driel, Willemien J.
    Leon-Castillo, Alicia
    Piek, Jurgen M. J.
    De Kroon, Cor D.
    Leemans, Jaklien C.
    Geomini, Peggy M. A. J.
    Lok, Christianne A. R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A38 - A38
  • [29] Outcome assessment of age group-specific (±50 years) post-remission consolidation with high-dose cytarabine or bone marrow autograft for adult acute myelogenous leukemia
    Bassan, R
    Raimondi, R
    Lerede, T
    D'emilio, A
    Buelli, M
    Borleri, G
    Personeni, A
    Bellavita, P
    Rodeghiero, F
    Barbui, T
    HAEMATOLOGICA, 1998, 83 (07) : 627 - 635
  • [30] Mathematical Optimization Strategy for Effectiveness Profile Estimation in Two-Dose Vaccines and Its Use in Designing Improved Vaccination Strategies Focused on Pandemic Containment
    Gonzalez-Sanchez, Oscar A.
    Zaldivar, Daniel
    Cuevas, Erik
    Gonzalez-Ortiz, L. Javier
    VACCINES, 2024, 12 (01)